Saliva sample for the massive screening of SARS-CoV-2 infection: a systematic review

Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 May;131(5):540-548. doi: 10.1016/j.oooo.2021.01.028. Epub 2021 Feb 1.

Abstract

Objective: This systematic review aims to describe the value of saliva as a noninvasive sample for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in comparison with the current method for sample collection, the nasopharyngeal swab.

Study design: We conducted a systematic review of the literature following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. We searched in 5 databases (PubMed, Cochrane, EBSCO, Elsevier, and MEDLINE) and included articles published between December 2019 and July 2020.

Results: This review included 22 publications that met inclusion criteria, 17 of which were case series, 2 of which were case reports, and 3 of which were massive screenings. All articles compared saliva with nasopharyngeal swabs. The detection rate of SARS-CoV-2 in saliva was similar to that for nasopharyngeal swabs. The sensitivity ranged between 20% and 97%, and specificity ranged between 66% and 100%.

Conclusions: This systematic review found that saliva might be an appropriate, fast, painless, simple, and noninvasive sample for SARS-CoV-2 detection, making it ideal for massive screening of SARS-CoV-2 infection.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • COVID-19*
  • Humans
  • Mass Screening
  • SARS-CoV-2*
  • Saliva